Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm
- PMID: 6284783
- DOI: 10.1210/jcem-55-3-531
Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm
Abstract
We have studied a 57-yr-old woman with cyclic Cushing's syndrome of apparent pituitary origin who had a predominant cycle of 2-6 days. The patient also demonstrated an abnormal circadian rhythm, with afternoon peaks of plasma ACTH and plasma cortisol. In addition to these abnormal biorhythms, Fourier analysis showed what appeared to be a separate 35-day cycle. After 35 days of consecutive urinary free cortisol measurement, the patient was given cyproheptadine. During therapy with this agent, the urinary free cortisol levels fell dramatically, but cyclic secretion continued, albeit with a diminished amplitude. During general anesthesia for a bilateral adrenalectomy, there was a striking increase in the plasma ACTH level, and the ACTH concentration remained high in both the immediate and late postoperative periods. These observations indicated that stress could overcome cyclic ACTH secretion and that cortisol exerted feedback suppression on ACTH secretion. Although this is the predictable response for classic pituitary-dependent Cushing's syndrome, it is of interest in cyclic Cushing's syndrome, since previous studies of this entity have implied that cortisol secretion is independent of stimulation or feedback.
Similar articles
-
Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.J Clin Endocrinol Metab. 1980 Nov;51(5):1195-8. doi: 10.1210/jcem-51-5-1195. J Clin Endocrinol Metab. 1980. PMID: 6252234
-
The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.J Clin Endocrinol Metab. 1985 Mar;60(3):527-35. doi: 10.1210/jcem-60-3-527. J Clin Endocrinol Metab. 1985. PMID: 2982900
-
A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease.N Engl J Med. 1981 Nov 19;305(21):1244-8. doi: 10.1056/NEJM198111193052103. N Engl J Med. 1981. PMID: 6270557
-
Evaluation and treatment of Cushing's syndrome.Am J Med. 2005 Dec;118(12):1340-6. doi: 10.1016/j.amjmed.2005.01.059. Am J Med. 2005. PMID: 16378774 Review.
-
Cushing's Syndrome: important issues in diagnosis and management.J Clin Endocrinol Metab. 2006 Oct;91(10):3746-53. doi: 10.1210/jc.2006-0997. Epub 2006 Jul 25. J Clin Endocrinol Metab. 2006. PMID: 16868050 Review.
Cited by
-
Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's disease.J Endocrinol Invest. 1988 Jun;11(6):425-8. doi: 10.1007/BF03349075. J Endocrinol Invest. 1988. PMID: 2850311
-
Cyproheptadine treatment in Cushing's disease.J Endocrinol Invest. 1996 Apr;19(4):242-7. doi: 10.1007/BF03349875. J Endocrinol Invest. 1996. PMID: 8862505
-
Cyclical Cushing's disease: report of a case cured by conventional cobaltotherapy.J Endocrinol Invest. 1987 Feb;10(1):89-93. doi: 10.1007/BF03347163. J Endocrinol Invest. 1987. PMID: 3598080
-
A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing's syndrome.BMC Endocr Disord. 2019 Oct 22;19(1):105. doi: 10.1186/s12902-019-0433-9. BMC Endocr Disord. 2019. PMID: 31640675 Free PMC article.
-
Cushing's syndrome with intermittent ectopic ACTH production.J Endocrinol Invest. 1990 Apr;13(4):317-26. doi: 10.1007/BF03349570. J Endocrinol Invest. 1990. PMID: 2164547
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical